Bridget E. Bunner

Array ( [id] => 6938542 [patent_doc_number] => 20050112105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Compositions and treatments for myelosuppression by ex vivo activated immune cells' [patent_app_type] => utility [patent_app_number] => 10/939168 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15359 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112105.pdf [firstpage_image] =>[orig_patent_app_number] => 10939168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 806409 [patent_doc_number] => 07419662 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-02 [patent_title] => 'Methods of making chemokine alpha 3 antibodies' [patent_app_type] => utility [patent_app_number] => 10/935306 [patent_app_country] => US [patent_app_date] => 2004-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19946 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/419/07419662.pdf [firstpage_image] =>[orig_patent_app_number] => 10935306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 359431 [patent_doc_number] => 07485310 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-03 [patent_title] => 'Use of CXCL6 chemokine in the prevention or repair of cartilage defects' [patent_app_type] => utility [patent_app_number] => 10/595072 [patent_app_country] => US [patent_app_date] => 2004-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 8811 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/485/07485310.pdf [firstpage_image] =>[orig_patent_app_number] => 10595072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7061127 [patent_doc_number] => 20050003488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Polypeptide, cDNA encoding the same, and use of them' [patent_app_type] => utility [patent_app_number] => 10/902777 [patent_app_country] => US [patent_app_date] => 2004-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9703 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003488.pdf [firstpage_image] =>[orig_patent_app_number] => 10902777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5068923 [patent_doc_number] => 20070190024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Il-11 muteins' [patent_app_type] => utility [patent_app_number] => 10/565626 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 18270 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190024.pdf [firstpage_image] =>[orig_patent_app_number] => 10565626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8151943 [patent_doc_number] => 08168429 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-01 [patent_title] => 'Method of amplifying hematopoietic stem cell and hematopoietic progenitor cell' [patent_app_type] => utility [patent_app_number] => 10/587014 [patent_app_country] => US [patent_app_date] => 2004-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10357 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168429.pdf [firstpage_image] =>[orig_patent_app_number] => 10587014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5770735 [patent_doc_number] => 20050266531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Compositions and methods for inhibiting liver stellate cell growth' [patent_app_type] => utility [patent_app_number] => 10/888962 [patent_app_country] => US [patent_app_date] => 2004-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9414 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266531.pdf [firstpage_image] =>[orig_patent_app_number] => 10888962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5678309 [patent_doc_number] => 20060183665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Modulators of the potassium channels twik-1, task-1 gorl1. sk2 pr pcn1, used to treat arrhythmia, coronary heat disease or hypertension' [patent_app_type] => utility [patent_app_number] => 10/565185 [patent_app_country] => US [patent_app_date] => 2004-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 2961 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183665.pdf [firstpage_image] =>[orig_patent_app_number] => 10565185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7202743 [patent_doc_number] => 20050042655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Novel hematopoietic regulatory factors and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/886160 [patent_app_country] => US [patent_app_date] => 2004-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22487 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042655.pdf [firstpage_image] =>[orig_patent_app_number] => 10886160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 869070 [patent_doc_number] => 07365171 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => 'Chemokine-like factors (CKLFs) with chemotactic and hematopoietic stimulating activities' [patent_app_type] => utility [patent_app_number] => 10/859414 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 27 [patent_no_of_words] => 13351 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/365/07365171.pdf [firstpage_image] =>[orig_patent_app_number] => 10859414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7255954 [patent_doc_number] => 20050143297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Method for the administration of ligands, agonists of ligands of the TNF family with reduced toxicity' [patent_app_type] => utility [patent_app_number] => 10/853514 [patent_app_country] => US [patent_app_date] => 2004-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5570 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143297.pdf [firstpage_image] =>[orig_patent_app_number] => 10853514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7422614 [patent_doc_number] => 20040229317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/851185 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 23863 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229317.pdf [firstpage_image] =>[orig_patent_app_number] => 10851185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7154354 [patent_doc_number] => 20050026248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Novel mammalian G-protein coupled receptors having extracellular leucine rich repeat regions' [patent_app_type] => utility [patent_app_number] => 10/851470 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9450 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026248.pdf [firstpage_image] =>[orig_patent_app_number] => 10851470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5219269 [patent_doc_number] => 20070160580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Interferon gamma therapies for idiopathic pulmonary fibrosis' [patent_app_type] => utility [patent_app_number] => 10/556487 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16613 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20070160580.pdf [firstpage_image] =>[orig_patent_app_number] => 10556487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7432389 [patent_doc_number] => 20040209816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Treatment for diabetes' [patent_app_type] => new [patent_app_number] => 10/843780 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10987 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209816.pdf [firstpage_image] =>[orig_patent_app_number] => 10843780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7428364 [patent_doc_number] => 20040209328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Human tumor necrosis factor receptor TR16' [patent_app_type] => new [patent_app_number] => 10/841471 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 131953 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209328.pdf [firstpage_image] =>[orig_patent_app_number] => 10841471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7343560 [patent_doc_number] => 20040191829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/834850 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 24448 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191829.pdf [firstpage_image] =>[orig_patent_app_number] => 10834850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 273938 [patent_doc_number] => 07560102 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-14 [patent_title] => 'Method for reducing neuronal degeneration so as to ameliorate the effects of injury or disease' [patent_app_type] => utility [patent_app_number] => 10/810653 [patent_app_country] => US [patent_app_date] => 2004-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 50 [patent_no_of_words] => 22734 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 249 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/560/07560102.pdf [firstpage_image] =>[orig_patent_app_number] => 10810653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7677189 [patent_doc_number] => 20040152637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'DNA molecule encoding a variant alpha-2B-adrenoaceptor protein and uses thereof' [patent_app_type] => new [patent_app_number] => 10/809860 [patent_app_country] => US [patent_app_date] => 2004-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5200 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152637.pdf [firstpage_image] =>[orig_patent_app_number] => 10809860 [rel_patent_id] =>[rel_patent_doc_number] =>)